SMITHS GROUP SERVICES CORPORATION for SMITHS GROUP SERVICES CORPORATION
What was lobbied
12 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reimbursement and policy issues related to non-opioid acute pain management.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Defense DEF
FY19 National Defense Authorization; FY18 Department of Defense Appropriations Act (H.R.3219); FY19 Defense Appropriations; Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and detection solutions for the Department of Defense.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Aviation/Airlines/Airports AVI
H.R.2825, Department of Homeland Security Authorization Act; Aviation security solutions and detection technologies for the Transportation Security Administration (TSA).
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Trade (domestic/foreign) TRD
Issues related to the North American Free Trade Agreement (NAFTA).
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LILIA LORREIN RAMIREZ | — |
Taxation/Internal Revenue Code TAX
H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.4617, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on the medical device excise tax; H.R.195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes (P.L.115-120); H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123). Issues related to the repeal of the medical device excise tax; tax reform; international tax issues; manufacturing and taxes.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Budget/Appropriations BUD
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures: FY18 Defense and FY18 DHS Appropriations in H.R.1370, Further Additional Continuing Appropriations Act, 2018 (P.L.115-96), H.R.195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes (P.L.115-120), H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123), H.R.1625, Consolidated Appropriations Act, 2018 (P.L.115-141). FY19 DHS Appropriations, Transportation Security Administration (TSA) funding; FY19 Defense Appropriations, Chemical Biological Funding; FY19 Commerce, Justice, Science Appropriations, Opioid Funding; FY19 Labor HHS Bill, Reimbursement for Medical Devices. Support DoD and DOE funding in FY19 for Columbia Class ballistic missile submarine development. Support DoD funding request for Virginia Class submarine construction, Virginia Class submarines, and submarine upgrades in FY19. Request additional funding to FY19 Navy SCN, Columbia Class Submarine Advance Procurement Funding for Supplier Base Reconstitution.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
| LILIA LORREIN RAMIREZ | — |
| KEVIN SCHMIDT | — |
Medicare/Medicaid MMM
S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Environment/Superfund ENV
Issues related to climate change and emissions technologies.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Energy/Nuclear ENG
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Homeland Security HOM
FY18 Department of Homeland Security Appropriations Act (H.R.3355); FY2019 DHS Appropriations; Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS), U.S. Customs and Border Protection (CBP) and the Domestic Nuclear Detection Office (DNDO). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Medical/Disease Research/Clinical Labs MED
Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; issues related to patient infusion therapy. H.R.195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes (P.L.115-120); H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123); issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Medical device technology related to the opioid epidemic.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Torts TOR
H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; H.R.3487, To amend section 1332 of title 28, United States Code, to provide that the requirement for diversity of citizenship jurisdiction is met if any one party to the case is diverse in citizenship from any one adverse party in the case; Issues related to tort reform.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.